The US President's Malaria Initiative, transmission and mortality: A modelling study
Peter Winskill and colleagues estimate the influence the US President's Malaria Initiative funding has had on averting malaria-related cases and deaths over the past decade and the potential impact if PMI funding is reduced going forward.
Vyšlo v časopise:
The US President's Malaria Initiative, transmission and mortality: A modelling study. PLoS Med 14(11): e32767. doi:10.1371/journal.pmed.1002448
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002448
Souhrn
Peter Winskill and colleagues estimate the influence the US President's Malaria Initiative funding has had on averting malaria-related cases and deaths over the past decade and the potential impact if PMI funding is reduced going forward.
Zdroje
1. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;8: 207–211. doi: 10.1038/nature15535 26375008
2. Alonso PL, Tanner M. Public health challenges and prospects for malaria control and elimination. Nat Med. 2013;19: 150–155. doi: 10.1038/nm.3077 23389615
3. Snow RW, Guerra CA, Mutheu JJ, Hay SI. International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission. PLoS Med. 2008;5: 1068–1078. doi: 10.1371/journal.pmed.0050142 18651785
4. Cohen JM, Smith DL, Cotter C, Ward A, Yamey G, Sabot OJ, et al. Malaria resurgence: a systematic review and assessment of its causes. Malar J. 2012;11: 122. doi: 10.1186/1475-2875-11-122 22531245
5. World Health Organization. World Malaria Report. Geneva; 2016.
6. USAID. The President’s Malaria Initiative: Tenth Annual Report to Congress. 2016.
7. Korenromp EL, Hosseini M, Newman RD, Cibulskis RE. Progress towards malaria control targets in relation to national malaria programme funding. Malar J. 2013;12: 18. doi: 10.1186/1475-2875-12-18 23317000
8. Jakubowski A, Stearns SC, Kruk ME, Angeles G, Thirumurthy H. The US President’s Malaria Initiative and under-5 child mortality in sub-Saharan Africa: A difference-in-differences analysis. PLoS Med. 2017;14: e1002319. doi: 10.1371/journal.pmed.1002319 28609442
9. Department of State. Congressional Budget Justification. 2017.
10. Foundation KF. Congress Releases FY17 Omnibus [Internet]. 2017 [cited 25 May 2017]. Available: http://kff.org/news-summary/congress-releases-fy17-omnibus/
11. Griffin JT, Bhatt S, Sinka ME, Gething PW, Lynch M, Patouillard E, et al. Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study. Lancet Infect Dis. Griffin et al. 2016;3099: 1–8. doi: 10.1016/S1473-3099(15)00423-5 26809816
12. Griffin JT, Ferguson NM, Ghani AC. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa. Nat Commun. Nature Publishing Group; 2014;5: 3136. doi: 10.1038/ncomms4136 24518518
13. White MT, Griffin JT, Churcher TS, Ferguson NM, Basáñez MG, Ghani AC. Modelling the impact of vector control interventions on Anopheles gambiae population dynamics. Parasit Vectors. 2011;4: 153. doi: 10.1186/1756-3305-4-153 21798055
14. Griffin JT, Hollingsworth TD, Reyburn H, Drakeley CJ, Riley EM, Ghani AC. Gradual acquisition of immunity to severe malaria with increasing exposure. Proc Biol Sci. 2015;282. doi: 10.1098/rspb.2014.2657 25567652
15. Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W, et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. Krishna S, editor. PLoS Med. Public Library of Science; 2010;7: e1000324. doi: 10.1371/journal.pmed.1000324 20711482
16. World Health Organization. World Malaria Report. Geneva; 2015.
17. Cohen JM, Woolsey AM, Sabot OJ, Gething PW, Tatem AJ, Moonen B. Public health. Optimizing investments in malaria treatment and diagnosis. Science. 2012;338: 612–614. doi: 10.1126/science.1229045 23118172
18. World Health Organization. World malaria report 2013. Geneva; 2013.
19. Garske T, Ferguson NM, Ghani AC. Estimating Air Temperature and Its Influence on Malaria Transmission across Africa. PLoS ONE. 2013;8. doi: 10.1371/journal.pone.0056487 23437143
20. Gething PW, Patil AP, Smith DL, Guerra C a., Elyazar IRF, Johnston GL, et al. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J. 2011;10: 378. doi: 10.1186/1475-2875-10-378 22185615
21. CIESIN. Gridded Population of the World (GPW), v4 [Internet]. 2016. [cited 2017 Jan 12]: Available: http://beta.sedac.ciesin.columbia.edu/data/collection/gpw-v4
22. Bhatt S, Weiss D, Mappin B, Dalrymple U, Cameron E, Bisanzio D, et al. Coverage and system efficiencies of insecticide-treated nets in Africa from 2000 to 2017. Elife. 2015;4: e09672. doi: 10.7554/eLife.09672 26714109
23. PMI. PMI contributions to fight malaria [Internet]. 2017 [cited 25 May 2017]. Available: https://www.pmi.gov/about
24. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of Artemisinin Resistance in Plasmodium falciparum Malaria. N Engl J Med. 2014;371: 411–423. doi: 10.1056/NEJMoa1314981 25075834
25. Brech V, Potrafke N. Donor ideology and types of foreign aid. J Comp Econ. Association for Comparative Economic Studies; 2014;42: 61–75. doi: 10.1016/j.jce.2013.07.002
26. World Health Organization. Cost effectiveness and strategic planning (WHO-CHOICE) [Internet]. [cited 2017 Jun 6]: Available: http://www.who.int/choice/en/
27. Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015;93: 118–124. doi: 10.2471/BLT.14.138206 25883405
28. Lu C, Schneider MT, Gubbins P, Leach-Kemon K, Jamison D, Murray CJ. Public financing of health in developing countries: a cross-national systematic analysis. Lancet. Elsevier Ltd; 2010;375: 1375–1387. doi: 10.1016/S0140-6736(10)60233-4 20381856
29. Gething PW, Kirui VC, Alegana VA, Okiro EA, Noor AM, Snow RW. Estimating the number of paediatric fevers associated with malaria infection presenting to Africa’s public health sector in 2007. PLoS Med. 2010;7. doi: 10.1371/journal.pmed.1000301 20625548
30. Comfort AB, Van Dijk JH, Thuma PE, Mharakurwa S, Gabert R, Korde S, et al. Hospitalizations and costs incurred at the facility level after scale-up of malaria control: Pre-post comparisons from two hospitals in Zambia. Am J Trop Med Hyg. 2014;90: 20–32. doi: 10.4269/ajtmh.13-0019 24218409
31. Kieny MP, Evans DB, Schmets G, Kadandale S. Health-system resilience: reflections on the Ebola crisis in western Africa. Bull World Health Organ. 2014;92: 850. doi: 10.2471/BLT.14.149278 25552765
32. Plucinski MM, Guilavogui T, Sidikiba S, Diakit?? N, Diakit?? S, Dioubat?? M, et al. Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: A cross-sectional survey of health facilities. Lancet Infect Dis. 2015;15: 1017–1023. doi: 10.1016/S1473-3099(15)00061-4 26116183
33. Walker PGT, White MT, Griffin JT, Reynolds A, Ferguson NM, Ghani AC. Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis. Lancet Infect Dis. Elsevier; 2015; doi: 10.1016/S1473-3099(15)70124-6 25921597
34. White MT, Conteh L, Cibulskis R, Ghani AC. Costs and cost-effectiveness of malaria control interventions—a systematic review. Malar J. 2011;10: 337. doi: 10.1186/1475-2875-10-337 22050911
35. Walker PG, Floyd J, FO ter K, Cairns M. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. PLoS Med. 2017;14: e1002243. doi: 10.1371/journal.pmed.1002243 28245259
36. Sachs JD, Malaney P. The economic and social burden of malaria. Nature. 2002;415: 680–685. doi: 10.1038/415680a 11832956
37. World Health Organization. Global technical strategy for malaria 2016–2030 [Internet]. Geneva, Switzerland; 2015 p. 29.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2017 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
- HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project
- Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study
- Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial